Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance (Q91552287)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 September 2018

Language	Label	Description	Also known as
English	Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance	scientific article published on 16 September 2018

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Joseph R Grajo

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Michael S Gee

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Alex Benjamin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Rebecca E Zubajlo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Kai E Thomenius

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Brian W Anthony

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Anthony E Samir

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

publication date

16 September 2018

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

number of pages

15

1 reference

based on heuristic

inferred from page(s)

Ultrasound in Medicine and Biology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

44

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

2461-2475

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The impact of sound speed errors on medical ultrasound imaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Acoustic properties of normal and cancerous human liver-II. Dependence of tissue structure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Shear wave dispersion measures liver steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Mouse liver dispersion for the diagnosis of early-stage Fatty liver disease: a 70-sample study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Shear wave dispersion in lean versus steatotic rat livers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Backscatter coefficient imaging using a clinical scanner

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

NAFLD: a multisystem disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-alcoholic fatty liver disease: the mist gradually clears

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasonography to quantify hepatic fat content: validation by 1H magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Interobserver reproducibility of the controlled attenuation parameter (CAP) for quantifying liver steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A new method for attenuation coefficient measurement in the liver: comparison with the spectral shift central frequency method.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Comprehensive compilation of empirical ultrasonic properties of mammalian tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Variation of ultrasound image lateral spectrum with assumed speed of sound and true scatterer density.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Repeatability and Reproducibility of a Clinically Based QUS Phantom Study and Methodologies

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Robust sound speed estimation for ultrasound-based hepatic steatosis assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Studies on frequency-dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral-shift zero-crossing method

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Computed ultrasound tomography in echo mode for imaging speed of sound using pulse-echo sonography: proof of principle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasound in the detection of chronic liver disease (the “bright liver”)

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Secondary causes of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A new method for measuring the speed of sound in rat liver ex vivo using an ultrasound system: correlation of sound speed with fat deposition

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Correlation of Fourier spectral shift-determined hepatic acoustic attenuation coefficients with liver biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Estimating the total ultrasound attenuation along the propagation path by applying multiple filters to backscattered echoes from a single spherically focused source

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A theoretical comparison of attenuation measurement techniques from backscattered ultrasound echoes

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Radiologic evaluation of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Correlations of sound speed with tissue constituents in normal and diffuse liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The global NAFLD epidemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasound backscatter and attenuation in human liver with diffuse disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Detecting hepatic steatosis using ultrasound-induced thermal strain imaging: an ex vivo animal study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Attenuation of ultrasound in normal liver and diffuse liver disease in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

An evaluation of hepatic ultrasound speed in injury models in rats: correlation with tissue constituents

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Comparison of ultrasound attenuation and backscatter estimates in layered tissue-mimicking phantoms among three clinical scanners

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Sound speed correction in ultrasound imaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Phase aberration correction in medical ultrasound using speckle brightness as a quality factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Ultrasonic propagation properties (@ 100 MHz) in excessively fatty rat liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Principles of ultrasound elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Effect of Short-Term Vitamin D Correction on Hepatic Steatosis as Quantified by Controlled Attenuation Parameter (CAP).

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

In-vivo measurements of ultrasound attenuation in normal or diseased liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Noninvasive in vivo quantitative assessment of fat content in human liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Pulse-echo ultrasound speed measurements: progress and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Donor selection for adult-to-adult living donor liver transplantation: well begun is half done

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-invasive diagnosis of hepatic steatosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Interobserver and intraobserver variability in the sonographic assessment of fatty liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Computer-aided B-mode ultrasound diagnosis of hepatic steatosis: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Liver glycogen and water storage: effect on ultrasound attenuation

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Backscatter coefficient measurements using a reference phantom to extract depth-dependent instrumentation factors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Hepatitis C virus (HCV) infection and hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Quantitative ultrasound imaging: in vivo results in normal liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.ULTRASMEDBIO.2018.07.019

7 January 2021

Identifiers

10.1016/J.ULTRASMEDBIO.2018.07.019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30232020%20AND%20SRC:MED&resulttype=core&format=json

23 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q91552287&oldid=2034710258"